Tianjin Tianyao Pharmaceuticals (600488.SH) subsidiary receives registration certificate from the Ministry of Health of the Dominican Republic for injection of methylprednisolone sodium succinate.
Jin Medicine Industry (600488.SH) announced that its subsidiary, Jin Medicine Heping (Tianjin) Pharmaceutical Co., Ltd. (...
Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary, Jin Yaoheping (Tianjin) Pharmaceutical Co., Ltd. (referred to as "Jin Yaoheping"), has obtained the registration certificate from the Ministry of Health of the Dominican Republic for the injection of methylprednisolone sodium succinate (referred to as "the drug"), indicating that the product can now be produced and sold in the Dominican Republic market. Methylprednisolone sodium succinate is a type of corticosteroid drug used primarily for anti-inflammatory treatment, immunosuppressive treatment, treatment of blood disorders, tumor treatment, and shock treatment.
Related Articles

JACOBSON PHARMA (02633) announces profit growth, expected to increase by over 10% year-on-year for the 2025 fiscal year.

VITASOY INT'L (00345) announced an expected annual net profit attributable to equity holders of HK$225 million to HK$245 million, an increase of approximately 94% to 111% year-on-year.

GEELY AUTO (00175) issued a total of 121,900,000 shares on May 26 due to the exercise of subscription rights.
JACOBSON PHARMA (02633) announces profit growth, expected to increase by over 10% year-on-year for the 2025 fiscal year.

VITASOY INT'L (00345) announced an expected annual net profit attributable to equity holders of HK$225 million to HK$245 million, an increase of approximately 94% to 111% year-on-year.

GEELY AUTO (00175) issued a total of 121,900,000 shares on May 26 due to the exercise of subscription rights.

RECOMMEND

Xiaomi Unveils 3nm Chip and YU7 SUV at 15th Anniversary Event
23/05/2025

BYD Surpasses Tesla in European EV Sales for the First Time in April with 169% Surge; Tesla Sees 45% Q1 Decline, Musk Reaffirms CEO Role for Five More Years
23/05/2025

U.S. FTC Officially Withdraws Case Against Microsoft’s $69 Billion Acquisition of Activision Blizzard
23/05/2025